Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,310.00
+75.00 (1.77%)
Feb 21, 2025, 9:00 AM KST

Meta Biomed Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Other Revenue
-0-0-0-0--
Upgrade
Revenue
92,30083,10168,94258,78044,99859,391
Upgrade
Revenue Growth (YoY)
16.03%20.54%17.29%30.63%-24.24%12.94%
Upgrade
Cost of Revenue
49,78945,11039,74633,77825,38933,256
Upgrade
Gross Profit
42,51137,99029,19625,00319,60826,136
Upgrade
Selling, General & Admin
24,05821,65118,68215,45513,35916,224
Upgrade
Research & Development
5,5304,5384,3433,3392,2272,453
Upgrade
Operating Expenses
30,53527,38823,83119,74117,09420,383
Upgrade
Operating Income
11,97610,6025,3655,2612,5145,753
Upgrade
Interest Expense
-3,309-2,315-1,390-1,145-1,011-1,190
Upgrade
Interest & Investment Income
437.53375.03206.7829.8231.3639.92
Upgrade
Earnings From Equity Investments
---537.62468.69392.13
Upgrade
Currency Exchange Gain (Loss)
989.08232.84-523.931,509-1,236-5.77
Upgrade
Other Non Operating Income (Expenses)
944.46-861.26-734.591,171433.051,087
Upgrade
EBT Excluding Unusual Items
11,0398,0342,9237,3641,2006,076
Upgrade
Gain (Loss) on Sale of Investments
1,177773.17426.74-39.83-335.36-134.9
Upgrade
Gain (Loss) on Sale of Assets
-31.2412.6247.62801.18180.36-2.83
Upgrade
Asset Writedown
-1,015-1,015-487.37-541.23-4,661-13.81
Upgrade
Pretax Income
11,1707,8052,9107,584-3,6165,925
Upgrade
Income Tax Expense
-3,889-2,22364.5-1,938-529.21170.82
Upgrade
Earnings From Continuing Operations
15,05910,0272,8469,521-3,0875,754
Upgrade
Earnings From Discontinued Operations
149.53-211.99754.18140.51-1,003-2,181
Upgrade
Net Income to Company
15,2099,8153,6009,662-4,0903,573
Upgrade
Minority Interest in Earnings
134.08265-972.22-140.45-3.75-226.66
Upgrade
Net Income
15,34310,0802,6289,522-4,0933,346
Upgrade
Net Income to Common
15,34310,0802,6289,522-4,0933,346
Upgrade
Net Income Growth
108.45%283.61%-72.40%---
Upgrade
Shares Outstanding (Basic)
232323232323
Upgrade
Shares Outstanding (Diluted)
362323232323
Upgrade
Shares Change (YoY)
56.31%-0.06%-0.07%-0.61%-1.08%-0.68%
Upgrade
EPS (Basic)
670.85440.75114.82415.77-177.66143.66
Upgrade
EPS (Diluted)
405.80440.75114.82415.77-177.66143.36
Upgrade
EPS Growth
27.27%283.85%-72.38%---
Upgrade
Free Cash Flow
6,036-1,271-6,2369,0692,634-4,696
Upgrade
Free Cash Flow Per Share
168.84-55.59-272.48396.00114.32-201.62
Upgrade
Dividend Per Share
20.00020.00020.00020.00010.00010.000
Upgrade
Dividend Growth
0%0%0%100.00%0%0%
Upgrade
Gross Margin
46.06%45.72%42.35%42.54%43.58%44.01%
Upgrade
Operating Margin
12.98%12.76%7.78%8.95%5.59%9.69%
Upgrade
Profit Margin
16.62%12.13%3.81%16.20%-9.10%5.63%
Upgrade
Free Cash Flow Margin
6.54%-1.53%-9.04%15.43%5.85%-7.91%
Upgrade
EBITDA
16,63314,8259,2258,8326,4559,466
Upgrade
EBITDA Margin
18.02%17.84%13.38%15.03%14.35%15.94%
Upgrade
D&A For EBITDA
4,6574,2233,8603,5713,9413,713
Upgrade
EBIT
11,97610,6025,3655,2612,5145,753
Upgrade
EBIT Margin
12.98%12.76%7.78%8.95%5.59%9.69%
Upgrade
Effective Tax Rate
--2.22%--2.88%
Upgrade
Advertising Expenses
-151.08230.86245.85141.51197.87
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.